Amendment 2858 to health care bill

Nearly all US rules require that generic drug companies repeat 
clinical trials.  Even though there will be no scientific 
benefit.  And will slow down the release of the generic.  And add to 
its costs.  Because the results are known; the drug is safe; that's 
why the generic companies want to make it.

Sanders Amendment 2858 would allow generic safety to be based on the 
original non-generic trials, without repeating them.

This is good.

Thank Senator Sanders 
<http://sanders.senate.gov/contact/>http://sanders.senate.gov/contact/ 
and let your own Senator know.
(Yes, it's a big nuisance to use the web contact forms.  But if not us, who?)

or add your name here, by sending an email as directed: 
<http://keionline.org/ethicalpathwayletter>http://keionline.org/ethicalpathwayletter 


Unless, by Tuesday, December 8 I get feedback disagreeing, I'm going 
to sign for People Who.

Sylvia



Powered by LSoft's LISTSERV(R) list management software